Corbion NV

CORB.EU

$19.93

Closing

▼-0.53%

1D

▼-3.35%

YTD

Market cap

$1.18B

52 week high

$32.53

52 week low

$15.47

Volume

83,057

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $3.99/month

Market cap

$1.18B

Analysts' Rating

BUY

Price Target (Mean)

27.34738612

Total Analysts

0

P/E

15.18

Operating Margin

7.26%

Beta

1.00

Revenue Growth (Annual)

21.26%

52 week high

$32.53

52 week low

$15.47

Div. Yield

3.26%

EPS Annual Growth

0.00

Note on Purification and Zakat

  • Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly). 
  • If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
  • For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them. 

Company Profile

Corbion NV is a company based in the Netherlands that is active in the field of biochemical ingredients. The Company’s products include lactic acid derivatives, emulsifiers, functional enzyme blends, minerals and vitamins, among others. It operates through two business lines: Ingredient Solutions, divided into business segments Food and Biochemicals, as well as Innovation Platforms. The Food segment develops preservation ingredients and microbial spoilage prevention products for the baking, meat, dairy, confectionery and beverage industries, and the Biochemicals segment produces bio-based chemicals derived from renewable resources such as sugar or starch. The Innovation Platforms segment creates new biotechnology business platforms, such as the poly lactic acid (PLA) bioplastic or its algae ingredients business. The Company operates production sites in the United States, Brazil, Spain, the Netherlands and Thailand, and markets its products through a global network of retail offices.